Aug 5, 2026

What Makes an AI Product Enterprise-Ready? A Business Leader’s Perspective

Most AI pilots never make it to production. Here are the five questions business leaders should ask before approving, buying, or scaling an AI product.

Author

Shivangi Agarwal
Shivangi AgarwalContent Writer
What Makes an AI Product Enterprise-Ready? A Business Leader’s Perspective

Table of Contents

Have you ever wondered why your pilot gets shelved just a few months after the demo? Your demo probably was successful. Even gave quick AI answers, with detailed summaries and suggestions. 

What if we were to tell you- it's not a coincidence?

Let's look at some stats:

  • 95% of generative AI pilots deliver no measurable impacts even with an estimated $30–40 billion in enterprise spend- MIT Report
  • 80% of organizations report no meaningful enterprise-wide EBIT impact from AI- McKinsey
  • 78% of organizations use AI in at least one business function, yet only 7% say AI is fully scaled across their organization.- McKinsey Global Survey

The pattern must be clear now: enterprise-ready AI is not the AI with the best demo. It is the AI a large organization can trust to run inside real workflows, with governed data, accountable humans, visible costs and provable outcomes.

Before approving, purchasing or scaling any AI product, ask these 5 questions as a business leader.

Five Questions to Ask Before Scaling an AI Product

Ask this questionLook for

Let’s explore these questions at length.

1. What Business Outcome Does The AI Product Improve?

A common misconception is that businesses buy “AI”.

On the contrary, it invests in a measurable improvement to a  business process. Anything from lower cost per transaction, faster resolution times, fewer errors to higher conversion rates.

73% of failed AI initiatives had no agreed definition of success before they started, according to an analysis of 5 separate studies by Gartner, MIT, RAND, BCG, McKinsey.

Other red flags you might want to spot early:

  • unclear definitions of success
  • chasing technology rather than outcomes
  • and fading executive sponsorship

The problem usually stems from not being able to draw a direct line between AI capabilities and business metrics. 

The byline?

Your product is not ready to scale, it's ready for another demo. And so, demand the basics: a clear baseline, a clear target KPI, a clear business owner, and a means of assigning results to the AI.

2. What Workflow Does The AI Product Fit Into?

An AI product creates value only when it lives inside the actual flow of work.

This “learning gap”, according to MIT’s 2025 research, does not retain feedback or adapt to the context in your current workflow.

A straightforward method to understand where it currently fits into your workflow:

Who uses the AI, and at what step?

It should pertain to a specific role and step. An example would be a support agent seeing a suggested comment when he opens his tickets.

What happens before and after its output?

The output needs to be activated by a real-life event and sent directly to the next step. Either the draft reply gets sent to the agent to review or it gets forwarded to the customer.

Which system of record will the outcome reside?

The outcome must land in the same system where the work is done, whether it is a CRM, ERP, or ticketing system, without any copy-paste between different systems.

What decision rights are there?

Low-risk outcomes will be sent automatically while high-risk outcomes will need human approval while the unsure ones will be escalated.

Ideally, the workflow should be designed around AI and human judgement.

3. What Data and Systems Does The AI Product Depend on?

An AI product cannot be more enterprise-ready than the data and systems beneath it.

Gartner predicts that through 2026, organizations will abandon 60% of AI projects unsupported by AI-ready data, and 63% of organizations admit they lack, or are unsure of, the right data management practices for AI. 

This is often the place where the difference between the prototype and the actual production system comes into play.
Prototype — built to prove the ideaProduction — built to run the business

Another important factor is Integration with actual CRM, ERP and legacy systems. It takes much more time than expected, and is one of the main reasons behind overruns of both budget and schedule.

Ask early, and ask specifically.

4. What Controls and Accountability Sit Around The AI Product?

Much like the data beneath it, governance too must live inside the product — not in a policy document. This includes the access control, audit logs, human checks, versioning of the model and prompt, and a plan for incident response and rollback.

A common wall most business leaders hit: How much control is enough?

Well, the short answer is that controls should be proportionate to autonomy.

A writing assistant just needs to know about privacy basics whereas an agent that governs your business systems needs stricter permission boundaries and tool-level controls. 

Which leads us to a follow-up — Who owns the outcome?

5. What Proves The AI Product will Hold at Scale?

And that brings us to our final question— one that will separate a promising pilot from a viable investment.

While a successful pilot proves feasibility, production has to prove economic viability. 

Data consistently shows production GenAI deployments typically cost 3-5 times the initial projection- of which the $684 billion invested in AI in 2025, an estimated $547 billion failed to deliver its intended business value.

So before scaling, ask for evidence across 3 things:

  • Usage: Are people actually adopting it, coming back to it, trusting its output enough to act on it? 
  • Trust: Do task-success rates, error rates and uptime hold once real users and real data arrive? 
  • Economics: What does each successful task cost, including the human review around it, and when does it pay back?
If your product can show all three, it's ready. 

The Bridge from Prototype to Production

None of this implies that companies must slow their work down. It means the work around the model matters more than the model

It’s precisely this bridge that GeekyAnts assists businesses in crossing: going from validated use case to production system, from individual model to workflow, from experiment to governed business capability. 

The reality is that the winning AI is not the one that makes a good demo. Rather, the one still running, still trusted, and still paying for itself a year later.

SHARE ON

Subscribe to Our Newsletter

Related Articles.

More from the engineering frontline.

Dive deep into our research and insights on design, development, and the impact of various trends to businesses.

Why Legacy Systems Block Real-Time AI Decision-Making
Article

Aug 5, 2026

Why Legacy Systems Block Real-Time AI Decision-Making

Learn how legacy systems limit real-time AI decision-making and what businesses can do to build an AI-ready infrastructure.
Building AI-Powered Banking CRM Platforms Without Replacing Core Banking Systems
Article

Aug 4, 2026

Building AI-Powered Banking CRM Platforms Without Replacing Core Banking Systems

Banks can modernize CRM with AI without replacing their core banking systems. This guide covers the architecture, use cases, governance, and roadmap to do it.
AI in Fintech: Everyone's Talking, Few are Shipping
Article

Jul 31, 2026

AI in Fintech: Everyone's Talking, Few are Shipping

This blog covers the key engineering, governance, and compliance principles required to build production-ready AI systems for financial services.
How to Build Medical Device Software with AI: Compliance, Architecture, and Development Process
Article

Jul 28, 2026

How to Build Medical Device Software with AI: Compliance, Architecture, and Development Process

A guide for engineering leaders on building compliant, production-ready AI medical device software, from architecture to FDA clearance.
ERP and MES Integration for U.S. Pharma Manufacturers: A Roadmap to Achieve Zero-Error Production and End-to-End Traceability
Article

Jul 28, 2026

ERP and MES Integration for U.S. Pharma Manufacturers: A Roadmap to Achieve Zero-Error Production and End-to-End Traceability

A strategic roadmap for U.S. pharma leaders integrating ERP and MES to reduce production errors, accelerate batch release, strengthen compliance readiness, and enable end-to-end traceability across manufacturing sites.
Why Healthcare Organizations Are Moving Beyond Telehealth Toward AI-Driven Care Systems
Article

Jul 22, 2026

Why Healthcare Organizations Are Moving Beyond Telehealth Toward AI-Driven Care Systems

Why healthcare organizations are moving past telehealth toward AI systems that run care operations, and what leaders need to get there.
Scroll for more
View all articles